Quality dossiers start with seasoned writers

AMCP formulary dossiers offer a comprehensive view of the US clinical, safety, and economic evidence for new and existing medical drugs, tests, and devices, helping health care decision makers make coverage and reimbursement decisions and ensure that patients have access to much-needed care. These dossiers have thus been widely adopted by the industry as an effective way to ensure these decision makers have current, complete, and accurate information.

Dossiers must contain the most recent, relevant, scientifically accurate and balanced information regarding pharmaceutical products, while also remaining free of any promotional material. Key sections of a dossier generally include product information and disease background, clinical evidence, and an economic value and model report. Once a dossier has been compiled and approved, it may be reviewed and updated when there are significant changes regarding the pharmaceutical product, such as changes to the prescribing information, new clinical or economic evidence, new safety information, and demonstrations of real-world or long-term effectiveness. Given the amount and complexity of information in these documents, they are understandably time consuming to create and maintain.

At Med Communications, we understand the importance of communicating your product’s value effectively in order to facilitate formulary additions and optimize reimbursement. Our clients trust us to develop and maintain valuable and strategic product dossiers across various therapeutic areas. Our highly experienced, knowledgeable medical writers effectively convey the evidence-based value of your product to decision makers and stakeholders. For more information: 877-477-0977 or https://medcommunications.com/contact-us.